Reply to: "Efficacy and safety of doxycycline versus iodopovidone for pleurodesis through an intercostal tube in malignant pleural effusions: a randomized trial"
- PMID: 38909347
- DOI: 10.1007/s00520-024-08670-5
Reply to: "Efficacy and safety of doxycycline versus iodopovidone for pleurodesis through an intercostal tube in malignant pleural effusions: a randomized trial"
Comment on
-
Efficacy and safety of doxycycline versus iodopovidone for pleurodesis through an intercostal tube in malignant pleural effusions: a randomized trial.Support Care Cancer. 2023 Jul 10;31(8):454. doi: 10.1007/s00520-023-07932-y. Support Care Cancer. 2023. PMID: 37428348 Clinical Trial.
References
-
- Damaraju V, Sehgal IS, Muthu V, Prasad KT, Dhooria S, Aggarwal AN et al (2023) Efficacy and safety of doxycycline versus iodopovidone for pleurodesis through an intercostal tube in malignant pleural effusions: a randomized trial. Support Care Cancer 31:454. https://doi.org/10.1007/s00520-023-07932-y - DOI - PubMed
-
- Boutron I, Dutton S, Ravaud P, Altman DG (2010) Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 330:2058–2064. https://doi.org/10.1001/jama.2010.651 - DOI
-
- Chow R, Huang E, Fu S, Kim E, Li S, Sodhi J et al (2022) Spin in randomized controlled trials in obstetrics and gynecology: a systematic review. Womens Health Rep (New Rochelle) 3:795–802. https://doi.org/10.1089/whr.2021.0141 - DOI - PubMed
-
- Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291:2457–2465. https://doi.org/10.1001/jama.291.20.2457 - DOI - PubMed
-
- Lamb C, Li A, Thakkar D, Lee P (2019) Pleurodesis. Semin Respir Crit Care Med 40:375–385. https://doi.org/10.1055/s-0039-1693997 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources